Referral of responders with chemosensitive relapsed/refractory DLBCL to HCT associated with improved OS
Referral of patients with relapsed/refractory chemotherapy-sensitive diffuse B-cell lymphoma who achieved a partial or better response to transplantation resulted in improved overall survival compared with those who underwent additional lines of therapy. Patients with chemotherapy-sensitive relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who have achieved a partial response (PR) or complete response (CR) and are referred …